Safety of Ramelteon in Elderly Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Insomnia
Interventions
DRUG

Ramelteon, zolpidem and placebo

"Ramelteon 8 mg, tablets, orally, one night only during Period 1, 2 or 3~Zolpidem 10 mg, tablets, orally, one night only during Period 1, 2 or 3~Ramelteon/Zolpidem placebo-matching tablets, orally one night only during Period 1, 2 or 3"

Trial Locations (6)

Unknown

Costa Mesa

San Diego

Miami

Miramar

Orlando

New York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT00568789 - Safety of Ramelteon in Elderly Subjects | Biotech Hunter | Biotech Hunter